Company: ARMP
Filing Date: 2025-06-13
Form Type: 8-K
Source: 0001104659-25-059346
Chunk: 0

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-06-13
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item 5.07.      Submission of Matters to a Vote of Security Holders.  

At the Annual Meeting of Shareholders held on June 12, 2025 (the
“ Meeting”), the shareholders of Armata Pharmaceuticals, Inc. (the “ Company”) elected seven members to our
board of directors, each for a one-year term expiring at the annual meeting of shareholders in 2026, as follows:

  Members                                                                
 ─────────────────────────────────────────────────────────────────────────
  Deborah L. Birx, M. D.         30,184,288      103,824      1,190,014  
  Jules Haimovitz                30,188,915       99,197      1,190,014  
  Odysseas D. Kostas, M. D.      30,190,453       97,659      1,190,014  
  Robin C. Kramer                30,231,763       56,349      1,190,014  
  Joseph M. Patti, Ph. D.        30,231,464       56,648      1,190,014  
  Todd C. Peterson, Ph. D.       30,228,440       59,672      1,190,014  
  Sarah Schlesinger, M. D.       30,149,529      138,583      1,190,014  

At the Meeting, our shareholders next approved, on a non-binding advisory
basis, the compensation of the Company’s named executive officers. The vote for such approval was 30,180,386 shares for, 75,804
shares against, 31,922 shares abstaining, and 1,190,014 shares of broker non-votes.

Also at the Meeting, our shareholders ratified the appointment of Ernst &
Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. The vote for such ratification
was 31,471,009 shares for, 4,970 shares against, 2,147 shares abstaining, and 0 shares of broker non-votes.

- 2 -

SIGNATURES